TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has issued an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced the convening of its 2025 first extraordinary general meeting to discuss and potentially approve a Share Incentive Scheme. This scheme includes granting restricted stock units (RSUs) to key executives, which could impact the company’s operational strategies and stakeholder interests by aligning management incentives with company performance.
The most recent analyst rating on (HK:2190) stock is a Buy with a HK$27.00 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing medical devices and technologies, with a significant presence in the Chinese market.
Average Trading Volume: 640,864
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.37B
For an in-depth examination of 2190 stock, go to TipRanks’ Overview page.